BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18544970)

  • 1. Molecular analysis of nipple fluid for breast cancer screening.
    Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ
    Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer.
    Higgins SA; Matloff ET; Rimm DL; Dziura J; Haffty BG; King BL
    Breast Cancer Res; 2005; 7(6):R1017-22. PubMed ID: 16280052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiberoptic ductoscopy for breast cancer patients with nipple discharge.
    Shen KW; Wu J; Lu JS; Han QX; Shen ZZ; Nguyen M; Barsky SH; Shao ZM
    Surg Endosc; 2001 Nov; 15(11):1340-5. PubMed ID: 11727147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
    Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
    Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk.
    Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomorphology as a risk predictor: experience with fine needle aspiration biopsy, nipple fluid aspiration, and ductal lavage.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):827-43, viii-ix. PubMed ID: 16308095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient variables that predict atypical cytology by nipple duct lavage.
    Bushnaq ZI; Ashfaq R; Leitch AM; Euhus D
    Cancer; 2007 Apr; 109(7):1247-54. PubMed ID: 17326050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk.
    Sauter ER; Daly M; Linahan K; Ehya H; Engstrom PF; Bonney G; Ross EA; Yu H; Diamandis E
    Cancer Epidemiol Biomarkers Prev; 1996 Dec; 5(12):967-70. PubMed ID: 8959318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ductal approaches to assessment and management of women at high risk for developing breast cancer.
    Locke I; Mitchell G; Eeles R
    Breast Cancer Res; 2004; 6(2):75-81. PubMed ID: 14979910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nipple aspirate fluid color is associated with breast cancer.
    Sauter ER; Winn JN; Dale PS; Wagner-Mann C
    Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.
    Visvanathan K; Santor D; Ali SZ; Brewster A; Arnold A; Armstrong DK; Davidson NE; Helzlsouer KJ
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):950-5. PubMed ID: 17507621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid.
    Fackler MJ; Malone K; Zhang Z; Schilling E; Garrett-Mayer E; Swift-Scanlan T; Lange J; Nayar R; Davidson NE; Khan SA; Sukumar S
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3306-10. PubMed ID: 16740751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal lavage in the screening of high-risk women.
    Kenney PJ; Ellison MC
    Curr Womens Health Rep; 2003 Apr; 3(2):151-5. PubMed ID: 12628085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
    Arun B; Valero V; Logan C; Broglio K; Rivera E; Brewster A; Yin G; Green M; Kuerer H; Gong Y; Browne D; Hortobagyi GN; Sneige N
    Clin Cancer Res; 2007 Aug; 13(16):4943-8. PubMed ID: 17699874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nipple fluid cytology.
    Masood S; Khalbuss WE
    Clin Lab Med; 2005 Dec; 25(4):787-94, vii-viii. PubMed ID: 16308092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery.
    Kuerer HM; Goldknopf IL; Fritsche H; Krishnamurthy S; Sheta EA; Hunt KK
    Cancer; 2002 Dec; 95(11):2276-82. PubMed ID: 12436432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast carcinogenesis: can the examination of ductal fluid enhance our understanding?
    Baltzell K; Eder S; Wrensch M
    Oncol Nurs Forum; 2005 Jan; 32(1):33-9. PubMed ID: 15660141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of high risk women to produce nipple aspirate fluid does not exclude detection of cytologic atypia in random periareolar fine needle aspiration specimens.
    Sharma P; Klemp JR; Simonsen M; Welsko CM; Zalles CM; Kimler BF; Fabian CJ
    Breast Cancer Res Treat; 2004 Sep; 87(1):59-64. PubMed ID: 15377851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.